RN7SKP147

Across TCGA pan-cancer cohorts, RN7SKP147 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RN7SKP147 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RN7SKP147 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP147 expression acts as an unfavorable survival marker.

BRCA, STAD, and ACC are the cancer types where RN7SKP147 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.117	0.580	<.001	84	view →
STAD	DFS	Tertile	All	0.440	0.721	.006	36	view →
ACC	OS	Tertile	All	0.147	0.685	.018	36	view →
KIRC	OS	Tertile	All	0.261	0.634	.003	24	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RN7SKP147–BRCA (OS)

Open the BRCA breakdown →